In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin

International Journal of Antimicrobial Agents

Volumn 23, Issue 5, 2004, Pages 513-516

  Alou, Luis ^a   Cafini, Fabio ^a   Sevillano, David ^a   Unzueta, Irune ^a   Prieto, José ^a  

^a Facultad de Medicina   (Spain)

Author keywords

Catheters; Prophylaxis; Vascular graft infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; PSEUDOMONIC ACID;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; TITRIMETRY;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; COAGULASE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 2342527147     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.09.030     Document Type: Article

References (18)

1. Giacometti A., Cirioni O., Ghiselli R., et al. Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin- intermediate Staphylococcus epidermidis vascular-graft infection. Antimicrob. Agents Chemother. 44:2000;2842-2844
2. Dieterich H.J., Groh J., Behringer K., Lauterjung L., Martin E. The prophylactic activity of amoxycillin/clavulanate and cefoxitin in vascular surgery - a randomized clinical study. J. Antimicrob. Chemother. 24:1989;209-211
3. Ghiselli R., Giacometti A., Goffi L., et al. Prophylaxis against Staphylococcus aureus vascular graft infections with mupirocin-soaked, collagen-sealed dacron. J. Surg. Res. 99:2001;316-320
4. Gisby J., Bryant J. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob. Agents Chemother. 44:2000;255-260
5. Sutherland R., Boon R.J., Griffin K.E., Masters P.J., Slocombe B., White A.R. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob. Agents Chemother. 27:1985;495-498
6. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin. Infect. Dis. 35:2002;353-358
7. Perl T.M., Cullen J.J., Wenzel R.P., et al. Mupirocin and the Risk of Staphylococcus aureus Study Team Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. New Engl. J. Med. 346:2002;1871
8. Climo M.W., Patron R.L., Archer G.L. Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob. Agents Chemother. 43:1999;1747-1753
9. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in laboratory medicine. 3rd ed. Baltimore: Willians Wilkins; 1996. p. 330-96.
10. Bajaksouzian S., Visalli M.A., Jacobs M.R., Appelbaum P.C. Activities of levofloxacin, ofloxacin and ciprofloxacin, alone and in combination with amikacin, against Acinetobacters as determined by checkerboard and time-kill studies. Antimicrob. Agents Chemother. 41:1997;1073-1076
11. Cappelletty D.M., Rybak M.J. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:1996;677-683
12. Domoracki B.E., Evans A.M., Venezia R.A. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 44:2000;1394-1396
13. Visalli M.A., Jacobs M.R., Appelbaum P.C. Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:1998;2002-2005
14. Bajaksouzian S., Visalli M.A., Jacobs M.R., Appelbaum P.C. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrob. Agents Chemother. 40:1996;1973-1976
15. Casewell M.W., Hill R.L. In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 15:1985;523-531
16. Voesten H.G., Degener J.E., Dijkstra P.K., et al. Optimizing antimicrobial prophylaxis in reconstructive vascular surgery. J. Vasc. Dis. 22:1993;342-346
17. Finlay J.E., Miller L.A., Poupard J.A. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob. Agents Chemother. 41:1997;1137-1139
18. Terpstra S., Noordhoek G.T., Voesten H.G.J., Hendriks B., Degener J.E. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J. Hosp. Infect. 43:1999;195-202